New Information to "Keep In Mind" and Follow Up from Wednesday's Member Zoom Call
Thank you to all the members that attended FSLA’s Weekly Member’s Only Video Conference Call on Wednesday. This week’s topic was the Covid-19 Vaccine Scheduling and Discussion, with special guest speakers Brooke Flaherty-Tiner, the Senior Director of State Government Affairs with CVS, and Molly McKinstry, the Deputy Secretary of Division of Health Quality Assurance with AHCA. Our members who were unable to make it can watch the video here. A copy of the Power Point presentation is also available for download.
As we all now know, per the CDC contract with CVS/Walgreens, Florida is in the 2 week window where CVS/Walgreens is required to schedule all three vaccination clinics with all ALFs. The first round of ALF vaccination clinics are scheduled over a 3 week window, starting January 11.
FSLA has learned that during this scheduling window, residents at some communities are choosing not to wait and are getting their vaccine from their county health departments.
Please Keep in Mind that CVS/Walgreens vaccines are provided by Pfizer, while the vaccines provided by the county health departments may be from Pfizer or Moderna.
Please Keep In Mind to keep track of residents who get the vaccine from CVS/Walgreens or the county health department. Your community may want to consider keeping track of any residents who receive their vaccines from the county health department too, and which vaccine they received and the date of the vaccine to keep up with the 2nd dosage date.
Please Keep In Mind that per CDC Guidance on the interchangeability with other COVID-19 vaccine products – “Either of the currently authorized mRNA COVID-19 vaccines can be used when indicated; ACIP does not state a product preference.
Please Keep In Mind that these mRNA COVID-19 vaccines are not interchangeable with each other or with other COVID-19 vaccine products. The safety and efficacy of a mixed-product series have not been evaluated. Both doses of the series should be completed with the same product.
Please Keep In Mind if two doses of different mRNA COVID-19 vaccine products are inadvertently administered, no additional doses of either product are recommended at this time. Recommendations may be updated as further information becomes available or other vaccine types (e.g., viral vector, protein subunit vaccines) are authorized.”
We are checking with AHCA on the following:
- Whether there will be different consent forms if communities are switched from a pharmacy to Department of Health;
- When it may be possible to begin relaxing the 14-day quarantine and visitation closures once we're past the vaccine clinics; and
- When we can cut back on the daily ESS reporting.